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Abstract
The etiology of monoclonal gammopathy of undetermined significance (MGUS), the precur-
sor state of multiple myeloma (MM), is mostly unknown and no studies have been con-
ducted on the effect of diet on MGUS or progression from MGUS to MM. We aimed to
explore the association between common foods and MGUS and progression to MM. Data
from the population-based AGES Study (N = 5,764) were utilized. Food frequency question-
naire was used to assess dietary intake during adolescence, midlife, and late life. Serum
protein electrophoresis and serum free light-chain assay was performed to identify MGUS
(n = 300) and LC-MGUS cases (n = 275). We cross linked our data with the Icelandic Cancer
Registry to find cases of MM in the study group. We found that intake of fruit at least three
times per week during adolescence was associated with lower risk of MGUS when com-
pared to lower fruit consumption (OR = 0.62, 95% CI 0.41–0.95). We additionally found that
intake of fruit at least three times per week during the late life period was associated with
decreased risk of progressing from MGUS to MM (HR = 0.34, 95% CI 0.13–0.89) when com-
pared to lower intake. Adolescent intake of fruit may reduce risk of MGUS, whereas fruit
intake after MGUS onset may reduce risk of progressing to MM. Our findings suggest that
diet might alter the risk of developing MGUS and progression to MM.
Introduction
All cases of the plasma cell malignancy multiple myeloma (MM) are preceded by monoclonal
gammopathy of undetermined significance (MGUS) [1, 2], a premalignant asymptomatic
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condition characterized by the presence of an M-protein in serum or by abnormal ratio
between the free light-chains kappa and lambda (light-chain MGUS), without indication of
MM or other lymphoproliferative (LP) diseases [3–5]. The prevalence of MGUS is approxi-
mately 5% in those older than 70 years and increases with age [6]. It is estimated that average
risk of progression from MGUS to MM is approximately 1% per year [7, 8]. Light-chain
MGUS (LC-MGUS) has been described as a precursor to light-chain MM, with a prevalence of
0.7–0.8% [4, 5].
As previously reported, the etiology of MGUS and LC-MGUS is mostly unknown [9]. How-
ever, studies have reported a higher risk of MGUS among males [6], black race [10, 11], in
individuals with family history of MGUS and related diseases [12], in individuals with previous
personal or family history of immune-related conditions [13, 14], and recently in those who
have been largely exposed to Agent Orange, an herbicide and defoliant chemical [15]. The lit-
erature on the etiology of MM is more extensive. An elevated risk of MM has been found to be
associated with low occupation-based socioeconomic status, income, education [16], and high
body mass index (BMI) [9, 17, 18]. The International Agency for Research on Cancer has
recently concluded, that there is now adequate evidence behind the association between body
weight and MM [19]. We have recently shown that high BMI, measured during midlife (�50
years old), was associated with an increased risk of progressing from MGUS to MM and other
LP diseases later in life, suggesting that exposures that originate during the midlife period, and
perhaps earlier in life, play a role in the pathogenesis of MM and related diseases diagnosed
later in life [9]. Since obesity has various underlying causes this indicates that lifestyle-related
factors, such as diet, are important risk factors for MM. However, epidemiological evidence on
the effect of diet on MM is scarce and the results are inconclusive [20–24]. The strongest evi-
dence exists for fish intake, where inverse association has been reported in few case-control
studies [21, 24–26], two of which reported dose-response relationship [21, 25]. No studies, to
our knowledge, on the association between diet and MGUS or LC-MGUS have been con-
ducted. Additionally, MGUS has been detected in individuals as young as 10–19 years old
[27], emphasizing the importance of studying the effect of early and midlife exposures on
MGUS. Many of the residential regions in Iceland were relatively isolated during the first half
of the 20th century. Due to that, there was a considerable variation in diet across the country.
The inhabitants’ diets was largely limited to locally produced food available on side such as fish
in sea villages and livestock at the farm [28]. Availability of fruit and vegetables was limited
due to unfavorable weather conditions and limited import. Iceland is therefore an ideal forum
for dietary research due to extremes in intake of common food groups. During the second half
of the 20th century the diet became more westernized [29].
As all MM cases first go through the MGUS stage it is important to disentangle these associ-
ations with the objective to identify separate risk factors for MGUS, LC-MGUS, and progres-
sion to MM. The overarching aim of this study was therefore to analyze the association
between diet throughout the lifespan and risk of MGUS and LC-MGUS using population-
based data. Secondly, we aimed to analyze whether diet was a risk factor for progression to
MM and other LP diseases in individuals with MGUS or LC-MGUS.
Materials and methods
Study population
For this study we used data from the Age, Gene/Environment Susceptibility–Reykjavik Study
(AGES Study). The AGES Study is a continuation of the population-based Reykjavik Study,
initiated in 1967 when all residents, born 1907–1935, of the Reykjavik metropolitan area were
invited to participate in a prospective cohort study with the objective of examining risk factors
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for cardiovascular diseases. A total of 71% (n = 19,350) of the invited residents consented to
participate during the years of 1967–1996 [30–32]. Of the 11,549 Reykjavik Study cohort mem-
bers still alive in March 2002, when the AGES Study was initiated, 8,030 individuals were ran-
domly chosen to take part in the study. By 2006, when the study ended, 5,764 (71.8%) had
participated. Detailed description of the study and collection of data has been previously pub-
lished [32], however in short, data were collected during three separate examinations using
standardized protocols. The first visit included e.g. blood draw, anthropometry, electrocardi-
ography, and extensive questionnaire including e.g. health history, lifestyle practices, and food
history. The second examination included imaging protocols and the third examination
included e.g. dementia assessments and vision screening [32].
At study entry the participants signed an informed consent form. The study was approved
by the Icelandic Data Protection Authority, the Icelandic National Bioethics Committee
(VSN-00-063-V35), and the Institutional Review Board of the National Institute on Aging in
the USA.
Dietary habits across the lifespan
At AGES Study entry the participants provided retrospective information on dietary habits
during adolescence (14–19 years old) and midlife (40–50 years old), as well as information on
current dietary habits using a food frequency questionnaire. The questionnaire included a
total of 63 questions (16 from the adolescent period, 17 from the midlife period, and 30 from
the late life period) regarding intake of common foods and food groups i.e. total fish intake
(and additional question on salted or smoked fish), fish oil, total meat intake (and additional
question on salted or smoked meat), milk and milk products, fruit, vegetables (excluding pota-
toes), rye bread and flatbread, blood or liver sausage, oatmeal and muesli, potatoes, and whole
wheat bread. Only foods and food groups that were included in the questionnaire from all
three life stages were used for this study, except for whole wheat bread (midlife and late life
only). The participants reported frequency of intake in each time period using the following
response categories for meat, milk and milk products, fruit, vegetables, rye bread and flatbread,
blood or liver sausage, oatmeal and muesli, potatoes, and whole wheat bread: never, less than
once a week, 1–2 times a week, 3–4 times a week, 5–6 times a week, daily, and more than once a
day. For fish oil the categories were the same except for: more than once a day. The categories
for salted and smoked meat and fish were: never, less than once a month, 1–3 times a month, 1–
2 times a week, 3–6 times a week, and daily or more often. The food frequency questionnaire
included three questions on fish consumption; frequency of consumption of fish in salad or as
topping on bread, fish as main meal (including salted or smoked fish), and consumption of
salted or smoked fish separately. Weekly intake of fish meals and fish in salad or as topping
was combined into one variable and the daily total intake was converted into total fish portions
per week, as has been previously described [33]. The validation study of the midlife diet took
advantage of available data from a detailed nutrition study performed 18 years previously,
using dietary history and the present diet was validated using a 3-day dietary history as a refer-
ence method. The AGES food frequency questionnaire was found suitable to rank individuals
by their intake for most food groups from the midlife and late period [34, 35].
Ascertainment of outcomes
As previously described [9, 36], a conventional agarose-gel serum protein electrophoresis
(SPEP) was performed in 2013–2014 on all subjects from the AGES Study cohort to identify
MGUS cases. A 0.5 mL serum sample, collected at study entry (2002–2006), was obtained for
each study subject and samples with an equivocal or definite M-protein present on SPEP were
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then subjected to serum protein immunofixation for conformation and typing of the M-pro-
tein [6]. Serum free light chain (FLC) assay was performed on all samples [37]. The sensitivity
and specificity of the laboratory tests have been previously published [38]. All testing was done
by individuals blinded to all demographics and other details related to the samples.
MGUS cases were defined as having M-protein bands (detectable on SPEP or immunofixa-
tion) and an elevated M-protein concentration (�30g/L) [39]. LC-MGUS cases were defined
as having no visible M-protein, a pathological FLC ratio (<0.26 or >1.65) on FLC analysis,
and an increased free light-chain concentration (f-kappa >19.4 mg/L, f-lambda >26.3 mg/L)
[40]. We ascertained MM diagnosis and diagnosis of other LP diseases through linkage with
the nationwide Icelandic Cancer Registry [41]. The start date of follow-up was at AGES Study
entry (March 2002-February 2006) until March 2014.
Exclusion from analysis
For this study we excluded a total of 40 (0.7%) subjects from analysis, 21 due to previous LP
diseases, 16 due to missing blood sample, one due to absent consent form, and one subject had
high M-protein concentration at baseline and therefore fulfilled criteria for smoldering MM.
One subject was additionally excluded from the progression analysis due to lack of follow-up.
Our analyses include individuals responding to the dietary questions, ranging from 5,270 to
5,304 from the adolescent period, from 5,279 to 5,301 from the midlife period, and from 507–
511 from the late life period, depending on the question.
Statistical analysis
A total of 12 food items were analyzed for the adolescent period and 13 for both midlife
and the late life period. Logistic regression was used to estimate odds ratios (OR) and 95%
confidence intervals (95% CI) for MGUS and LC-MGUS according to adolescent and
midlife diet. For each type of food or food group, participants were grouped according to
their frequency of intake or portions per week (total fish consumption only). Each type of
food or food group was analyzed in an age and sex adjusted model (Model 1) and addi-
tionally in a fully adjusted model where all the foods and food groups were simultaneously
added to one model, including age and sex (Model 2). An additional adjustment was
made for physical activity and BMI measured in midlife in the adolescent and midlife
models, and since the adjustment did not affect our results physical activity and BMI were
omitted from the models. Additionally, we cross-classified the intake from the adolescent
and midlife periods by combining individuals with low adolescent intake and low midlife
intake for each type of food and set them as a reference group for low and high, high and
low, and high and high intake at these time periods. We then used logistic regression to
test the association between the cross-classified categories of intake and MGUS and
LC-MGUS combined. Models were adjusted for age and sex.
Cox proportional hazard regression was used to test whether diet at study entry was a asso-
ciated with progression from MGUS/LC-MGUS to MM or other LP diseases. For this analysis
only individuals with MGUS and LC-MGUS were used, and due to few cases of MM and other
LP disease they were not analyzed separately. Results are presented as hazard ratios (HR) with
95% CI. All models were adjusted for sex and age at AGES Study entry. We further adjusted
our models for BMI and physical activity and we tested the association in a model where all
the foods were simultaneously added to one model. Due to few number of cases and therefore
low statistical power, and no effect on results, these analyses were not included in our results.
All analyses were performed in R version 3.3.3.[42]
Dietary intake is associated with risk of multiple myeloma and its precursor disease
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Sensitivity analysis
As described in detail previously [9, 36], we had an unusually high prevalence of LC-MGUS in
our cohort (4.8%), mainly due to a high prevalence of kappa cases (96%). The distribution of
log-transformed kappa and lambda values was found to resembled the normal distribution,
and therefore the cut-off for the involved chains was moved to the 97.5th percentile. A defini-
tion of LC-MGUS as a pathological FLC-ratio of< 0.26 and> 1.65, in combination with an
increased concentration of more than 40.0 mg/L of the light-chain involved was used to per-
form sensitivity analysis on the association between diet and MGUS/LC-MGUS.
Results
The mean age of participants was 77 years (range 66–98) at study baseline. MGUS and
LC-MGUS was identified in 300 (5.2%) and 275 (4.8%) subjects, respectively (Table 1). Using
the modified definition of LC-MGUS resulted in 52 cases. By cross linking the AGES Study
cohort to the Icelandic Cancer Registry we found that 18 participants progressed to MM, of
which one from LC-MGUS during a median follow-up of 8 years. Additionally, 11 progressed
to other LP diseases (Hodgkin’s, Non-Hodgkin’s lymphoma, Waldenstro¨m’s macroglobuline-
mia, lymphoid leukemia, chronic lymphocytic leukemia, and acute lymphocytic leukemia), of
which two from LC-MGUS.
Adolescent intake
We found, in Model 2, that intake of fruit at least three times per week during the adolescent period
was associated with lower risk of MGUS when compared intake less than three times per week
(OR = 0.62, 95% CI 0.41–0.95). Consumption of other food items during that period was not asso-
ciated with MGUS (Table 2). Additionally, we found that intake of fish at least two times per week
was associated with higher risk of LC-MGUS (OR = 1.33, 95% CI 1.02–1.73) when compared to
intake less than two times per week. Adolescent consumption of other foods was not associated
with LC-MGUS (Table 2). In our sensitivity analysis we did not find any association between fish
intake and risk of LC-MGUS in Model 2 as we did in our primary analysis. No association was
found between consumption of other food items and LC-MGUS in our sensitivity analysis.
Midlife intake
We found in Model 2 that intake of whole wheat bread at least five times per week was associ-
ated with lower risk of MGUS (OR = 0.75, 95% CI 0.57–0.99) when compared to participants
Table 1. Characteristics of study participants at AGES study entry.
Without MGUS MGUS LC-MGUS MM LP
n = 5,150 (90.0%) n = 300 (5.2%) n = 275 (4.8%) n = 18 (3.1%)� n = 11 (5.1%)�
Gender, n. (%)
Female 3,046 (59.1) 141 (47.0) 119 (43.3) 10 (55.6) 13 (46.4)
Male 2,104 (40.9) 159 (53.0) 156 (56.7) 8 (44.4) 15 (53.6)
Mean age, years (range) 76.8 (66–98) 78.3 (67–93) 79.4 (66–97) 77.8 (69–87) 77.5 (68–87)
BMI, kg/m2 (mean) 27.0 26.7 27.0 27.2 26.5
BMI midlife, kg/m2 (mean) 25.2 25.5 25.6 26.2 26.2
�Proportion of cases that progressed from MGUS or LC-MGUS.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS—Light chain monoclonal gammopathy of undetermined significance, MM
—Multiple myeloma, LP—Other lymphoproliferative diseases.
https://doi.org/10.1371/journal.pone.0206047.t001
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with intake of less than five times per week. Intake of other foods from midlife was not associ-
ated with MGUS (Table 3). Midlife intake of the tested food items was not associated with
LC-MGUS (Table 3). In our sensitivity analysis we found in Model 2 that midlife intake of
Table 2. The association between diet in adolescence and MGUS and LC-MGUS.
Model 1a Model 2b
No MGUS MGUS LC-MGUS MGUS LC-MGUS MGUS LC-MGUS
n (%) n (%) n (%) OR 95%CI OR 95% CI OR 95%CI OR 95% CI
Fish
� 2 portions p/w 2,335 (49.1) 140 (52.2) 99 (40.7) 1.00 1.00 1.00 1.00
> 2 portions p/w 2,424 (50.9) 128 (47.8) 144 (59.3) 0.85 0.66–1.09 1.33 1.02–1.73 0.88 0.68–1.14 1.39 1.06–1.83
Fish oil
less than weekly 2,280 (47.6) 119 (44.4) 128 (52.7) 1.00 1.00 1.00 1.00
weekly or more 2,509 (52.4) 149 (55.6) 115 (47.3) 1.13 0.88–1.45 0.82 0.63–1.06 1.14 0.89–1.48 0.87 0.66–1.14
Salted fish
3 times a month or less 2,210 (46.4) 128 (47.8) 114 (46.9) 1.00 1.00 1.00 1.00
once p/w or more 2,555 (53.6) 140 (52.2) 129 (53.1) 0.85 0.66–1.10 0.84 0.64–1.09 0.95 0.71–1.26 0.89 0.66–1.21
Meat
2 times p/w or less 1,689 (35.3) 103 (38.6) 91 (37.6) 1.00 1.00 1.00 1.00
3 times p/w or more 3,093 (64.7) 164 (61.4) 151 (62.4) 0.87 0.67–1.12 0.89 0.68–1.17 0.89 0.68–1.15 0.86 0.62–1.14
Smoked/salted meat
3 times a month or less 3,111 (65.2) 184 (68.7) 157 (64.9) 1.00 1.00 1.00 1.00
Once a week or more 1,663 (34.8) 84 (31.3) 85 (35.1) 0.79 0.60–1.03 0.90 0.68–1.18 0.82 0.61–1.10 0.94 0.69–1.28
Milk and milk products
less than daily 1,074 (22.4) 65 (24.3) 63 (25.9) 1.00 1.00 1.00 1.00
daily 3,719 (77.6) 203 (75.7) 180 (74.1) 0.87 0.65–1.17 0.79 0.59–1.07 0.91 0.67–1.24 0.85 0.62–1.17
Fruit
2 times p/w or less 4,077 (85.3) 241 (89.9) 217 (89.7) 1.00 1.00 1.00 1.00
3 times p/w or more 701 (14.7) 27 (10.1) 25 (10.3) 0.71 0.47–1.06 0.75 0.49–1.15 0.62 0.41–0.95 0.81 0.52–1.26
Vegetables
2 times p/w or less 3,517 (73.5) 197 (73.8) 197 (81.1) 1.00 1.00 1.00 1.00
3 times p/w or more 1,265 (26.5) 70 (26.2) 46 (18.9) 1.06 0.80–1.41 0.71 0.51–0.99 1.17 0.87–1.57 0.78 0.55–1.10
Rye bread/flatbread
less than daily 2,481 (52.0) 141 (52.6) 120 (49.4) 1.00 1.00 1.00 1.00
daily 2,289 (48.0) 127 (47.4) 123 (50.6) 0.88 0.68–1.14 0.94 0.72–1.22 0.94 0.71–1.23 1.00 0.75–1.34
Sausage/liver
less than weekly 1,252 (26.1) 74 (27.6) 68 (28.0) 1.00 1.00 1.00 1.00
weekly or more 3,539 (73.9) 194 (72.4) 175 (72.0) 0.84 0.63–1.11 0.78 0.58–1.04 0.86 0.65–1.18 0.85 0.61–1.18
Oatmeal/muesli
2 times p/w or less 2,119 (44.4) 110 (41.4) 108 (44.6) 1.00 1.00 1.00 1.00
3 times p/w or more 2,650 (55.7) 156 (58.6) 134 (55.4) 1.02 0.79–1.31 0.84 0.64–1.09 1.09 0.83–1.44 0.93 0.70–1.24
Potatoes
less than daily 483 (10.1) 35 (13.1) 25 (10.3) 1.00 1.00 1.00 1.00
daily 4,300 (89.9) 233 (86.9) 217 (89.7) 0.76 0.52–1.10 0.99 0.64–1.51 0.81 0.55–1.20 1.04 0.67–1.63
aAdjusted for age and sex.
bAdjusted for age, sex and the other food groups.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS—Light chain monoclonal gammopathy of undetermined significance, OR
—Odds ratio, CI—confidence interval
https://doi.org/10.1371/journal.pone.0206047.t002
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Table 3. The association between midlife diet and MGUS and LC-MGUS.
Model 1a Model 2b
No MGUS MGUS LC-MGUS MGUS LC-MGUS MGUS LC-MGUS
n (%) n (%) n (%) OR 95%CI OR 95% CI OR 95%CI OR 95% CI
Fish
� 2 portions p/w 565 (11.8) 35 (13.1) 33 (13.6) 1.00 1.00 1.00 1.00
> 2 portions p/w 4,204 (88.2) 233 (86.9) 209 (86.4) 0.84 0.58–1.22 0.77 0.52–1.13 0.87 0.59–1.28 0.80 0.54–1.19
Fish oil
less than weekly 1,852 (38.7) 97 (36.3) 97 (39.9) 1.00 1.00 1.00 1.00
weekly or more 2,931 (61.3) 170 (63.7) 146 (60.1) 1.09 0.84–1.41 0.94 0.72–1.23 1.10 0.84–1.44 0.95 0.72–1.25
Salted fish
3 times a month or less 3,241 (67.8) 187 (69.8) 161 (66.3) 1.00 1.00 1.00 1.00
once p/w or more 1,541 (32.2) 81 (30.2) 82 (33.7) 0.81 0.62–1.07 0.91 0.67–1.20 0.82 0.60–1.13 0.90 0.65–1.25
Meat
2 times p/w or less 1,809 (37.8) 106 (39.6) 93 (38.3) 1.00 1.00 1.00 1.00
3 times p/w or more 2,977 (62.2) 162 (60.4) 150 (61.7) 0.94 0.73–1.21 1.03 0.78–1.35 0.93 0.72–1.21 1.00 0.76–1.32
Smoked/salted meat
3 times a month or less 3,530 (73.8) 199 (74.3) 170 (70.2) 1.00 1.00 1.00 1.00
Once a week or more 1,252 (26.2) 69 (25.7) 72 (29.8) 0.89 0.67–1.18 1.05 0.79–1.40 0.95 0.68–1.32 1.12 0.80–1.56
Milk and milk products
less than daily 1,957 (40.9) 99 (37.1) 90 (37.2) 1.00 1.00 1.00 1.00
daily 2,823 (59.1) 168 (62.9) 152 (62.8) 1.11 0.86–1.43 1.08 0.82–1.41 1.17 0.89–1.53 1.15 0.87–1.53
Fruit
2 times p/w or less 3,271 (68.4) 185 (69.0) 181 (74.5) 1.00 1.00 1.00 1.00
3 times p/w or more 1,512 (31.6) 83 (31.0) 62 (25.5) 1.10 0.84–1.44 0.88 0.65–1.19 1.19 0.87–1.62 0.84 0.60–1.18
Vegetables
2 times p/w or less 3,081 (64.6) 182 (68.2) 162 (66.7) 1.00 1.00 1.00 1.00
3 times p/w or more 1,692 (35.4) 85 (31.8) 81 (33.3) 0.92 0.70–1.20 1.02 0.77–1.34 0.84 0.62–1.14 1.11 0.81–1.52
Rye bread/flatbread
less than daily 3,264 (68.1) 185 (69.0) 166 (68.3) 1.00 1.00 1.00 1.00
daily 1,526 (31.9) 83 (31.0) 77 (31.7) 0.86 0.66–1.13 0.83 0.62-.1.10 0.91 0.68–1.22 0.84 0.62–1.15
Sausage/liver
less than weekly 2,322 (48.5) 123 (45.9) 112 (46.1) 1.00 1.00 1.00 1.00
weekly or more 2,466 (51.5) 145 (54.1) 131 (53.9) 1.05 0.82–1.35 1.00 0.77–1.30 1.07 0.82–1.39 1.00 0.76–1.33
Oatmeal/muesli
2 times p/w or less 2,910 (60.9) 147 (55.1) 140 (57.9) 1.00 1.00 1.00 1.00
3 times p/w or more 1,869 (39.1) 120 (44.9) 102 (42.1) 1.18 0.92–1.52 1.01 0.77–1.31 1.27 0.94–1.60 1.05 0.80–1.40
Potatoes
less than daily 742 (15.5) 48 (17.9) 40 (16.5) 1.00 1.00 1.00 1.00
daily 4,046 (84.5) 220 (82.1) 203 (83.5) 0.80 0.58–1.11 0.86 0.60–1.22 0.82 0.58–1.16 0.88 0.61–1.28
Whole wheat bread
4 times p/w or less 1,489 (31.2) 101 (38.1) 87 (36.1) 1.00 1.00 1.00 1.00
5 times p/w or more 3,291 (68.8) 164 (61.9) 154 (63.9) 0.76 0.59–0.98 0.83 0.64–1.09 0.75 0.57–0.99 0.86 0.64–1.15
aAdjusted for age and sex.
bAdjusted for age, sex and the other food groups.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS—Light chain monoclonal gammopathy of undetermined significance, OR
—Odds ratio, CI—confidence interval.
https://doi.org/10.1371/journal.pone.0206047.t003
Dietary intake is associated with risk of multiple myeloma and its precursor disease
PLOS ONE | https://doi.org/10.1371/journal.pone.0206047 November 1, 2018 7 / 15
meat at least three times per week and daily intake of rye bread and flatbread was associated
with lower risk of LC-MGUS (OR = 0.44, 95% CI 0.23–0.84 and OR = 0.32, 95% CI 0.14–0.78,
respectively) when compared to lower intake. No association was found between consumption
of other food items from the midlife periods and LC-MGUS in our sensitivity analysis.
Cross-classification across two time points
Looking at both the adolescent and midlife period together, no association was found between
any of the food items and MGUS/LC-MGUS (S1 Table). However, in our sensitivity analysis
(S2 Table) we found that daily intake of rye bread and flatbread and potatoes during both the
adolescent and midlife periods was associated with lower risk of MGUS/LC-MGUS when
compared to less than daily intake at both periods (OR = 0.70, 95% CI 0.55–0.95 and
OR = 0.63, 95% CI 0.45–0.96, respectively).
Progression to multiple myeloma and other lymphoproliferative diseases
We found, in a sex and age adjusted model, that fruit intake at least three times per week was
inversely associated with risk of progression to MM (HR = 0.34, 95% CI 0.13–0.89) when com-
pared to intake less than three times per week. The association remained statistically signifi-
cant when cases of other LP diseases were combined with MM cases (HR = 0.45, 95% CI 0.21–
0.96). Intake of other food items was not associated with risk of progression to MM and other
LP diseases (Table 4). Similar results were found when analyzing risk of progression in MGUS
cases only.
Discussion
In this population-based study we found, using a food frequency questionnaire for evaluation
of dietary intake during three separate time periods, that food intake may affect risk of MGUS,
and specifically that intake of fruit at least three times per week during adolescence and midlife
intake of whole wheat bread at least five times per week, was associated with lower risk of
MGUS when compared to lower intakes. Additionally, we found, albeit based on few cases,
that late life intake of fruit at least three times per week in individuals with MGUS or
LC-MGUS was associated with lower risk of progressing to MM and other LP diseases. Adjust-
ing for BMI and physical activity did not change the results. These findings suggest that dietary
habits might influence the etiology of MGUS and progression to MM and other LP diseases.
We found that intake of fruit at least three times per week during the adolescent period was
inversely associated with risk of MGUS later in life when compared to lower intake, and, based
on a small number of cases, we found that late life intake of fruit at least three times per week
in patients with MGUS or LC-MGUS was associated with lower risk of progression. The find-
ings are in accordance with other studies consistently showing high intake of fruit and other
plant foods to be inversely associated with different types of cancer [43, 44]. A review of find-
ings from the European Prospective Investigation into Cancer and Nutrition (EPIC) from
2014 reported an inverse association between fruit intake and cancer risk at some sites [43].
The literature regarding fruit and risk of MM is scarce. To date, only two studies have exam-
ined the role of fruit in the etiology of MM. Both are US-based case-control studies on adults
already diagnosed with MM, with no association reported [21, 23]. Major differences in the
amount (intake levels) and time of exposure (period of life) and time of assessment (exposure
assessed after MM diagnosis) could explain the discrepancy with regards to our study. A
potential biologic mechanism for our finding is perhaps the anti-carcinogenic effect of vitamin
C as it traps free radicals and protects against oxidation [45]. Nevertheless, very few partici-
pants reported daily or more than daily fruit intake in present study. Therefore, the cut-off for
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high intake of fruit in our study was three times per week or more. This would normally be
considered low intake, but due to the low frequency of fruit consumption the cut-off could not
Table 4. The association between late life diet and risk of progression from MGUS and LC-MGUS to multiple myeloma and other lymphoproliferative diseases.
Total Multiple
myeloma
Multiple myeloma
and other LP
Multiple
myeloma �
Multiple myeloma
and other LP�
n (%) n (%) n (%) HR 95%CI HR 95% CI
Fish
� 2 portions p/w 149 (29.2) 7 (41.2) 10 (35.7) 1.00 1.00
> 2 portions p/w 361 (70.8) 10 (58.8) 18 (64.3) 0.62 0.24–1.64 0.77 0.35–1.67
Fish oil
less than weekly 152 (29.9) 6 (35.3) 9 (32.1) 1.00 1.00
weekly or more 357 (70.1) 11 (64.7) 19 (64.9) 0.81 0.30–2.22 0.91 0.41–2.03
Salted fish
less than once a month 371 (72.7) 13 (76.5) 21 (75.0) 1.00 1.00
once a month or more 139 (27.3) 4 (23.5) 7 (25.0) 0.95 0.30–2.95 1.00 0.42–2.39
Meat
2 times p/w or less 186 (36.4) 5 (29.4) 6 (21.4) 1.00 1.00
3 times p/w or more 325 (63.6) 12 (70.6) 22 (78.6) 1.47 0.51–4.21 2.18 0.88–5.41
Smoked/salted meat
less than once a month 341 (66.7) 14 (82.4) 20 (71.4) 1.00 1.00
once a month or more 170 (33.3) 3 (17.6) 8 (28.6) 0.47 0.13–1.68 0.84 0.36–1.96
Milk and milk products
less than daily 223 (43.7) 8 (47.1) 10 (35.7) 1.00 1.00
daily 287 (56.3) 9 (52.9) 18 (64.3) 0.96 0.37–2.50 1.56 0.72–3.39
Fruits
2 times p/w or less 151 (29.5) 9 (52.9) 13 (46.4) 1.00 1.00
3 times p/w or more 360 (70.5) 8 (47.1) 15 (53.6) 0.34 0.13–0.89 0.45 0.21–0.96
Vegetables
2 times p/w or less 270 (52.9) 11 (64.7) 16 (57.1) 1.00 1.00
3 times p/w or more 240 (47.1) 6 (35.3) 12 (42.9) 0.54 0.20–1.49 0.78 0.36–1.67
Rye bread/flatbread
2 times p/w or less 225 (44.4) 10 (58.8) 15 (53.6) 1.00 1.00
3 times p/w or more 282 (55.6) 7 (41.2) 13 (46.4) 0.57 0.22–1.52 0.70 0.33–1.48
Sausage/liver
never 111 (21.8) 3 (17.6) 6 (21.4) 1.00 1.00
ever 398 (78.2) 14 (82.4) 22 (78.6) 1.40 0.40–4.88 1.07 0.43–2.64
Oatmeal/muesli
2 times p/w or less 265 (51.9) 9 (52.9) 17 (60.7) 1.00 1.00
3 times p/w or more 246 (48.1) 8 (47.1) 11 (39.3) 0.96 0.36–2.51 0.69 0.32–1.50
Potatoes
less than daily 220 (43.1) 7 (41.2) 12 (42.9) 1.00 1.00
daily 290 (56.9) 10 (58.8) 16 (57.1) 1.12 0.42–2.96 1.04 0.49–2.20
Whole wheat bread
4 times p/w or less 130 (25.5) 4 (23.5) 4 (14.3) 1.00 1.00
5 times p/w or more 380 (74.5) 13 (76.5) 24 (85.7) 1.02 0.33–3.15 1.93 0.66–5.56
�Models adjusted for age and sex.
Abbreviations: MGUS—Monoclonal gammopathy of undetermined significance, LC-MGUS–Light chain monoclonal gammopathy of undetermined significance, LP–
lymphoproliferative, OR—Odds ratio, CI—confidence interval.
https://doi.org/10.1371/journal.pone.0206047.t004
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be higher. The beneficial threshold for both risk of MGUS and progression to MM may there-
fore be low. Since access to fruit was limited in Iceland, especially during the adolescent period
for this population and in rural areas, it is possible that fruit intake was an indicator of higher
social status or overall healthier life-style, and therefore the higher intake individuals were at
lower risk for multiple health outcomes, including MGUS and MM.
Interestingly, we did not find an association between intakes of fish and fish liver oil and
MGUS or progression to MM. Although not significant, the point estimates in the progression
analysis were in the same direction as previous studies on the association between fish intake
and risk of MM have reported. A few case-control studies have reported an inverse association
between fish intake and risk of MM [21, 24–26], including two that have found a dose-
response relationship [21, 25]. Both of these studies report much lower fish intake than
reported in our study. A suggested mechanism for the association is the cancer preventive
effect of the polyunsaturated omega-3 essential fatty acid (n-3) [46]. Fish intake is a common
indicator for social status [47]. However, for the Icelandic population, fish was widely available
and the diet was characterized by a very high fish intake. Due to the high intake we do not
have a non-exposed reference group in our fish intake analysis. Although our population has a
uniquely high intake of fish, the most common types were lean fish, low in n-3. Nevertheless,
the Icelandic population has high levels of the marine derived n-3 in both diet and plasma,
even those with low intake of fish liver oil, a common supplement in Iceland, rich in n-3.[48]
Therefore, we cannot rule out the option that a possible beneficial threshold of n-3 might
already have been reached by our low intake fish and fish liver oil reference groups. Another
reason for not finding an association between fish consumption and MM in our study could
be the lack of a reference group in the study that did not consume fish.
We found that intake of whole wheat bread at least five time per week was inversely associ-
ated with MGUS when compared to lower intake. To date, only one study has analyzed the
association between whole grain intake and risk of MM. A case-control study based on 120
MM cases below the age of 75 years reported that high intake of whole grain foods was
inversely associated with MM risk in women (OR = 0.5, p� 0.05) but not in men [49]. Poten-
tial mechanisms that could mediate the effect of whole grains on MM risk have not been suffi-
ciently explored. However, whole grains have been suggested to have positive effects on long-
term insulin secretion [50] which could be of importance regarding MM since increased avail-
ability of IGF-1 can increase MM cell proliferation and prevent apoptosis [51].
We found inconsistency in LC-MGUS risk between our primary and sensitivity analyses
when analyzing associations with fish, meat, and rye bread and flatbread intake and addition-
ally when analyzing the association between rye bread and flatbread and potatoes and MGUS
(MGUS and LC-combined) in our cross-classification analysis. The prevalence of LC-MGUS
was 4.8% in our cohort, which is considerably higher than has been noted in previous studies
[4, 5]. Although this is an elderly population the difference is substantial. It is therefore difficult
to draw conclusions from the results.
The strength of our study is the well-established population-based cohort design with lim-
ited threat to both internal and external validity. Another major strength is the ability to study
dietary intake throughout the lifespan, as studying early life exposures is challenging yet also
important since many diseases originate early in life. Few studies have been able to provide
data on adolescent or midlife diet combined with detailed ascertainment of later life health
outcomes and we believe our study is unique in that aspect. Additionally, a major strength is
the utilization of a validated food frequency questionnaire since majority of the questions had
an acceptable correlation and the questionnaire was found suitable to rank individuals by their
intake for most food groups when compared to a reference method [34, 35].
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The mean age of our study population is 77 years and our cohort might represent a selec-
tion of participants that are healthier than the general population. Participants had to recall
their dietary habits many decades back in time which could result in a misclassification of
intake. Although, a previous study showed that food-related memory from childhood can be
as accurate as from current diet, particularly for foods items eaten daily or rarely [52]. How-
ever, participants did not know their MGUS status at the time of questioning, and we therefore
assume that the misclassification is non-differential. We did not have data on family history of
hematologic cancers or information on total energy intake and were therefore unable to adjust
for these factors. We do not know the true time of MGUS onset and therefore a misclassifica-
tion of follow-up times could be present in our progression analysis, however, the prevalence
of MGUS increases with age and by adjusting all our models for age we try to reduce the effect
of this misclassification. Another limitation is lack of correlation to the reference method for
midlife and late life intake of few food groups when the questionnaire was validated, possibly
due to the inability of the food record used as reference method to adequately reflect individual
intake of food items that are consumed less than four times a week [34, 35]. Validating early
diet does pose great challenges and it is expected that such studies are unable to follow ideal
procedures. Interpretation of our results are therefore limited by the results of the validation
studies. Adolescent diet has not and cannot be validated, however, the data show similar fre-
quency of intake according to residence in rural and coastal fishing areas, as documented in an
Icelandic household study from 1939 [28, 53]. We cannot truly distinguish what could be
smoldering multiple myeloma as we do not have bone marrow samples. Lastly, we cannot rule
out the option that our findings are due to chance. Some of our results from the adolescent
and midlife periods are limited by few number of MGUS or LC-MGUS cases in some catego-
ries, our progression analyses are additionally limited by few number of cases. Little is known
about the relationship between diet and MGUS/LC-MGUS and progression to MM and this
study can therefore be considered a hypothesis-generating study. Adjusting for multiple com-
parison is thought of as an insurance policy against mistakenly rejecting a null hypothesis,
given that the null hypothesis is correct [54]. Due to the number of tests performed in the
study the chances of rejecting a null hypothesis and obtaining positive results is high. However,
the nature of our study is to seek potential risk factors for MGUS/LC-MGUS and progression
to MM and we did not adjust for multiple testing in order not to increase the risk of missing
out on possible risk factors.
To conclude, in this population-based screening study we found that high intake of fruit
during the adolescent period and whole wheat bread during the midlife period may reduce the
risk of MGUS later in life and that high fruit intake in late life may reduce the risk of progress-
ing from MGUS/LC-MGUS to MM. Our findings suggest that food intake might alter the risk
of developing MGUS and progressing to MM. Future studies should focus on clarifying the
possible role of dietary habits in the pathogenesis of MGUS and MM.
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